Canopy Growth Corporation (CGC)
USD 2.83
(-7.21%)
USD 2.83
(-7.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 308.61 Million CAD | -57.15% |
| 2022 | 487.41 Million USD | -6.32% |
| 2021 | 520.28 Million CAD | -21.94% |
| 2020 | 666.53 Million CAD | -32.89% |
| 2019 | 993.17 Million CAD | 54.56% |
| 2018 | 642.57 Million CAD | 319.8% |
| 2017 | 153.06 Million CAD | 236.94% |
| 2016 | 45.42 Million CAD | 123.74% |
| 2015 | 20.3 Million CAD | 149.08% |
| 2014 | 8.15 Million CAD | 774.94% |
| 2013 | 931.65 Thousand CAD | 1255.1% |
| 2012 | 68.75 Thousand CAD | 162.85% |
| 2011 | 26.15 Thousand CAD | -8.4% |
| 2010 | 28.55 Thousand CAD | 3.96% |
| 2009 | 27.46 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 27.99 Million USD | 5.42% |
| 2023 Q3 | 53.14 Million USD | -7.75% |
| 2023 FY | 208.84 Million USD | -57.15% |
| 2023 Q1 | 86.21 Million USD | -20.96% |
| 2023 Q2 | 57.61 Million USD | -33.18% |
| 2023 Q4 | 31.05 Million USD | -41.58% |
| 2022 Q3 | 129.06 Million CAD | -4.89% |
| 2022 FY | 487.41 Million USD | -6.32% |
| 2022 Q1 | 108.85 Million CAD | -15.79% |
| 2022 Q4 | 109.07 Million USD | -15.49% |
| 2022 Q2 | 135.7 Million CAD | 24.66% |
| 2021 Q1 | 119.92 Million CAD | -28.27% |
| 2021 Q2 | 141.7 Million CAD | 18.17% |
| 2021 Q3 | 121.99 Million CAD | -13.91% |
| 2021 Q4 | 129.26 Million CAD | 5.96% |
| 2021 FY | 520.28 Million CAD | -21.94% |
| 2020 Q2 | 169.23 Million CAD | 2.77% |
| 2020 Q3 | 160.94 Million CAD | -4.9% |
| 2020 Q4 | 167.18 Million CAD | 3.88% |
| 2020 Q1 | 164.68 Million CAD | -40.71% |
| 2020 FY | 666.53 Million CAD | -32.89% |
| 2019 Q2 | 266.79 Million CAD | 23.52% |
| 2019 Q1 | 215.98 Million CAD | -5.75% |
| 2019 Q4 | 277.77 Million CAD | 21.57% |
| 2019 FY | 993.17 Million CAD | 54.56% |
| 2019 Q3 | 228.49 Million CAD | -14.36% |
| 2018 FY | 642.57 Million CAD | 319.8% |
| 2018 Q1 | 70.8 Million CAD | 23.59% |
| 2018 Q2 | 177.44 Million CAD | 150.6% |
| 2018 Q3 | 165.17 Million CAD | -6.91% |
| 2018 Q4 | 229.15 Million CAD | 38.74% |
| 2017 FY | 153.06 Million CAD | 236.94% |
| 2017 Q4 | 57.29 Million CAD | 30.77% |
| 2017 Q3 | 43.81 Million CAD | 51.8% |
| 2017 Q2 | 28.86 Million CAD | 24.95% |
| 2017 Q1 | 23.09 Million CAD | 28.18% |
| 2016 FY | 45.42 Million CAD | 123.74% |
| 2016 Q4 | 18.02 Million CAD | 66.75% |
| 2016 Q2 | 9.28 Million CAD | 27.02% |
| 2016 Q1 | 7.31 Million CAD | -1.31% |
| 2016 Q3 | 10.8 Million CAD | 16.35% |
| 2015 Q4 | 7.4 Million CAD | 36.12% |
| 2015 FY | 20.3 Million CAD | 149.08% |
| 2015 Q3 | 5.44 Million CAD | 25.2% |
| 2015 Q2 | 4.34 Million CAD | 40.16% |
| 2015 Q1 | 3.1 Million CAD | 2.84% |
| 2014 Q1 | 1.28 Million CAD | -14.03% |
| 2014 FY | 8.15 Million CAD | 774.94% |
| 2014 Q4 | 3.01 Million CAD | 4.55% |
| 2014 Q3 | 2.88 Million CAD | 15.73% |
| 2014 Q2 | 2.49 Million CAD | 94.43% |
| 2013 Q2 | 8266.00 CAD | -78.67% |
| 2013 Q3 | 28.24 Thousand CAD | 241.71% |
| 2013 FY | 931.65 Thousand CAD | 1255.1% |
| 2013 Q4 | 1.49 Million CAD | 5180.1% |
| 2013 Q1 | 38.75 Thousand CAD | 558.78% |
| 2012 Q4 | 5883.00 CAD | -54.49% |
| 2012 Q1 | 3627.00 CAD | -58.33% |
| 2012 Q2 | 22.07 Thousand CAD | 508.66% |
| 2012 Q3 | 12.92 Thousand CAD | -41.44% |
| 2012 FY | 68.75 Thousand CAD | 162.85% |
| 2011 Q4 | 8705.00 CAD | -14.4% |
| 2011 Q3 | 10.16 Thousand CAD | 178.22% |
| 2011 Q1 | 1624.00 CAD | -81.45% |
| 2011 FY | 26.15 Thousand CAD | -8.4% |
| 2011 Q2 | 3655.00 CAD | 125.06% |
| 2010 Q4 | 8755.00 CAD | -40.56% |
| 2010 Q3 | 14.72 Thousand CAD | 327.02% |
| 2010 Q2 | 3449.00 CAD | 402.04% |
| 2010 Q1 | 687.00 CAD | -92.17% |
| 2010 FY | 28.55 Thousand CAD | 3.96% |
| 2009 FY | 27.46 Thousand CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q3 | 18 Thousand CAD | 0.0% |
| 2009 Q4 | 8777.00 CAD | -51.25% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Theratechnologies Inc. | 72.75 Million USD | -324.171% |
| Harrow Health, Inc. | 89.97 Million USD | -243.003% |
| Dynavax Technologies Corporation | 219.14 Million USD | -40.825% |
| Biofrontera Inc. | 39.95 Million USD | -672.317% |
| Cronos Group Inc. | 96.7 Million USD | -219.112% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -3167.097% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -32.95% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -688.215% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 3327.8% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -617.021% |
| Radius Health, Inc. | 265.92 Million USD | -16.05% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -2129.534% |
| DURECT Corporation | 43.71 Million USD | -605.959% |
| ProPhase Labs, Inc. | 37.85 Million USD | -715.307% |
| Safety Shot Inc | 12.1 Million USD | -2448.454% |
| Phibro Animal Health Corporation | 260.29 Million USD | -18.56% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -9955.103% |
| Alvotech | 285.43 Million USD | -8.118% |
| Assertio Holdings, Inc. | 368.58 Million USD | 16.272% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 41.663% |
| Rockwell Medical, Inc. | 15.37 Million USD | -1907.35% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2251.409% |
| Procaps Group S.A. | 187.24 Million USD | -64.816% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 47.694% |
| SCYNEXIS, Inc. | 51.84 Million USD | -495.221% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -415.725% |
| Viatris Inc. | 5.96 Billion USD | 94.827% |
| OptiNose, Inc. | 85.1 Million USD | -262.635% |
| SIGA Technologies, Inc. | 22.04 Million USD | -1300.035% |
| Tilray Brands, Inc. | 251.35 Million USD | -22.778% |
| PetIQ, Inc. | 192.72 Million USD | -60.13% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2251.409% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 80.67% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -3071.465% |
| Alimera Sciences, Inc. | 62.64 Million USD | -392.665% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -93.841% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -40373.867% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -5143.501% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 1.758% |
| Journey Medical Corporation | 54.59 Million USD | -465.282% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -1632.933% |
| Alpha Teknova, Inc. | 45.85 Million USD | -572.954% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -1357.839% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -529.328% |
| PainReform Ltd. | 9.58 Million USD | -3120.054% |
| Cosmos Health Inc. | 26.18 Million USD | -1078.765% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -87.075% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -3041.069% |
| Embecta Corp. | 528.4 Million USD | 41.595% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -7632.381% |
| Talphera, Inc. | 11.99 Million USD | -2473.037% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 5.444% |
| Incannex Healthcare Limited | 30.05 Million USD | -926.886% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1366.632% |
| Shineco, Inc. | 17.94 Million USD | -1619.464% |
| Procaps Group, S.A. | 199.47 Million USD | -54.71% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -57.468% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -588.032% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 10.522% |
| Alvotech | 285.43 Million USD | -8.118% |
| Hempacco Co., Inc. | 7.59 Million USD | -3962.556% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -119.317% |
| Bright Green Corporation | 8.25 Million USD | -3639.425% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | -13.503% |
| Kamada Ltd. | 45.42 Million USD | -579.369% |
| Indivior PLC | 911 Million USD | 66.124% |
| Evoke Pharma, Inc. | 12.4 Million USD | -2386.857% |
| Flora Growth Corp. | 10.57 Million USD | -2817.194% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1366.632% |
| Evolus, Inc. | 189.75 Million USD | -62.633% |
| HUTCHMED (China) Limited | 436.23 Million USD | 29.255% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -100.222% |
| Akanda Corp. | 3.48 Million USD | -8759.173% |